EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, FLGT: Fulgent Genetics Inc

03 Nov 25 15:59
LAST:

23.10

CHANGE:
 0.66		OPEN:
22.52		HIGH:
23.12		ASK:
0.01		VOLUME:
174.1K
CHG(%):
2.94		PREV:
22.45		LOW:
22.06		BID:
11.94		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 2522.4623.1222.0623.11304.5K
31 Oct 2522.5122.7522.0622.45263.4K
30 Oct 2522.8323.0522.4622.58226.1K
29 Oct 2523.3123.4422.5122.73187.9K
28 Oct 2523.4423.5422.9423.43196.8K
27 Oct 2523.6323.7023.1423.31198.1K
24 Oct 2523.6223.8623.4623.74129.3K
23 Oct 2523.5123.7623.1523.62129.1K
22 Oct 2523.9724.1723.2923.50234.1K
21 Oct 2523.9824.6423.6923.97302.6K

COMPANY PROFILE

Name:Fulgent Genetics Inc
About:Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
Sector:Healthcare
Address:4399 Santa Anita Avenue, El Monte, CA, United States, 91731
Website:https://www.fulgentgenetics.com
CUSIP:359664109
CIK:0001674930
ISIN:US3596641098
FIGI:BBG00DR7LTG2
LEI:549300CL6P01M68QJ404

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.39 
Forward P/E:-44.02 
PEG Ratio:-0.14 
Price to Sales:2.27 
Price to Book:0.62 
Profit Margin:-0.17 
Operating Margin:-0.24 
Return on Assets:-0.04 
Return on Equity:-0.05 
EPS Ratio:-1.66 
Revenue:303.22M 
Shares:30.61M 
Market Cap:707.07M 

TECHNICAL INDICATORS

MA5:22.861.0%
MA10:23.240.6%
MA20:23.000.4%
MA50:22.532.5%
MA100:21.109.5%
MA200:19.6317.7%
STO9:38.37
STO14:30.14
RSI14:57.63
WPR14:-56.58
MTM14:0.35
ROC14:0.02 
ATR:0.75 
Week High:23.702.6%
Week Low:22.064.7%
Month High:24.646.7%
Month Low:22.0617.7%
Year High:24.646.7%
Year Low:14.5758.5%
Volatility:2.90